![Matthew Emmens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Emmens
No open positions remaining
Profile
Matthew W. Emmens is an American businessperson who has been at the head of 6 different companies is on the board of Bristol Myers Squibb Co. In his past career he occupied the position of Director at Vertex Pharmaceuticals, Inc., President & Director at Merck KGaA and President & Chief Executive Officer for EMD Pharmaceuticals, Inc. (a subsidiary of Merck KGaA), Non-Executive Chairman at Shire Plc, Chief Executive Officer for Shire Plc, President & Chief Executive Officer of Astra Merck, Inc. and Director-Investor Relations for New River Pharmaceuticals, Inc. Mr. Emmens received an undergraduate degree from Fairleigh Dickinson University.
Former positions of Matthew Emmens
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | 2021-05-03 |
| SHIRE | Chairman | 2014-04-28 |
| INCYTE CORPORATION | Director/Board Member | 2009-02-03 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Chief Executive Officer | 2008-05-22 |
Shire Acquisition, Inc.
 Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Director/Board Member | 2008-03-11 |
Training of Matthew Emmens
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops novel products | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
- Stock Market
- Insiders
- Matthew Emmens
